Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
8%
Ph phase_4
1
8%
Ph not_applicable
1
8%
Ph phase_3
4
33%
Ph phase_2
5
42%

Phase Distribution

1

Early Stage

5

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 2Efficacy & side effects
5(41.7%)
Phase 3Large-scale testing
4(33.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(10)
Other(1)

Detailed Status

Completed10
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (8.3%)
Phase 25 (41.7%)
Phase 34 (33.3%)
Phase 41 (8.3%)
N/A1 (8.3%)

Trials by Status

not_yet_recruiting18%
completed1083%
unknown18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12